CVR Medical Corp. (CRRVF)

CVR Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Selling, General & Admin	0.47	0.56	0.22	2.12	3.1	2.69
Research & Development	-0	0.03	0.06	2.08	1.99	1.13
Operating Expenses	0.52	0.54	0.03	4.95	6.35	3.89
Operating Income	-0.52	-0.54	-0.03	-4.95	-6.35	-3.89
Interest Expense	-0.08	-0.07	-0.07	-0.09	-0.16	-0.01
Interest & Investment Income	-	-	-	0.01	-	0.01
Currency Exchange Gain (Loss)	-0.15	0.01	0.03	0.08	-0.03	-0.02
Other Non Operating Income (Expenses)	-0.05	-0.05	-0.05	-0.04	-0.13	-0.06
EBT Excluding Unusual Items	-0.81	-0.65	-0.13	-5	-6.67	-3.98
Asset Writedown	-1.17	-1.17	-	-	-	-
Other Unusual Items	0.01	0.01	-0.05	-0.14	-0.77	-2.58
Pretax Income	-1.97	-1.82	-0.17	-5.14	-7.44	-6.55
Net Income	-1.97	-1.82	-0.17	-5.14	-7.44	-6.55
Net Income to Common	-1.97	-1.82	-0.17	-5.14	-7.44	-6.55
Shares Outstanding (Basic)	105	101	101	100	74	58
Shares Outstanding (Diluted)	105	101	101	100	74	58
Shares Change (YoY)	3.73%	0.08%	1.88%	35.32%	26.66%	101.94%
EPS (Basic)	-0.02	-0.02	-0.00	-0.05	-0.10	-0.11
EPS (Diluted)	-0.02	-0.02	-0.00	-0.05	-0.10	-0.11
Free Cash Flow	-0.37	-0.09	-0.18	-2.2	-4.36	-3.89
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.02	-0.06	-0.07
EBITDA	-0.52	-0.54	-0.03	-4.95	-6.35	-3.89
D&A For EBITDA	0	0	0	0	0	0
EBIT	-0.52	-0.54	-0.03	-4.95	-6.35	-3.89

Updated Dec 1, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.